New medical device platform takes flight: Global Health Sciences Fund invests in Canary Medical’s proprietary, “smart” implant technology designed to improve outcomes in post-surgical patients

/in

The Canary Health Implantable Reporting Processor (CHIRP) uses innovative sensor and novel communication technology in medical devices to enable remote patient monitoring. “Smart” medical devices will self-report on everything from patient activity to recovery and even treatment failure, without the need for physician intervention or a dependence upon patient compliance. May 17, 2018 13:06 ET […]

Read more

AmpliPhi Biosciences Reports First Quarter 2018 Financial Results and Business Highlights

/in

Announced positive topline results for the initial seven patients treated with AB-SA01 or AB-PA01 under ongoing expanded access program and presented detailed results for the first patient at a medical conference  Signed collaborative agreements with the U.S. Department of Veterans Affairs and the Westmead Hospital in Sydney  Completed two financings for combined gross proceeds of […]

Read more

Adherium to Present at the Chardan Digital Health Conference

/in

15 May 2018 San Mateo, CA – May 1, 2018: Adherium, an award-winning digital health company that improves medication adherence and patient outcomes, today announced the Company will be participating in the upcoming Chardan Digital Health Conference in San Francisco, CA on Tuesday, May 22, 2018. Arik Anderson, CEO, is scheduled to provide a business overview […]

Read more

Live Better With: World No Tobacco Day 2018

/in

When is World No Tobacco Day? World No Tobacco Day takes place annually on May 31. What is the reason for World No Tobacco Day? World No Tobacco Day is an annual awareness day sponsored by the World Health Organization (WHO) since 1987 to highlight the health risks associated with tobacco use and encourage governments to […]

Read more

Introducing Evaux – the skincare range made for cancer patients

/in

We’re always on the lookout for new, innovative, and most importantly helpful products to add to our growing catalogue. The newest addition to our site is the Evaux skincare range – developed especially for cancer patients. During chemo or radiotherapy, you may find that your usual skincare and beauty products do more harm than good. It may be time […]

Read more

AmpliPhi Biosciences Will Utilize NIAID Preclinical Services to Advance Development of Its Targeted Therapeutic Candidate for the Treatment of Resistant Staphylococcus Aureus

/in

PUBLIC COMPANY INFORMATION: NYSEAM: APHB “We are pleased and encouraged by the support from the NIAID and its commitment to studying the role of bacteriophage in combating infectious diseases” SAN DIEGO–(BUSINESS WIRE)–AmpliPhi Biosciences Corporation (NYSE American: APHB), a clinical-stage biotechnology company focused on precisely targeted bacteriophage therapeutics for antibiotic-resistant infections, today announced that it will […]

Read more

Adherium Announces Program with Vitalus Health on World Asthma Day

/in

01 May 2018 San Mateo, CA – May 1, 2018: In conjunction with World Asthma Day, Adherium (ASX: ADR), a digital health company that improves medication adherence and patient outcomes, announced today it has agreed to launch a program with Vitalus Health, targeting patients with chronic obstructive pulmonary disease (COPD) using the Adherium Smartinhaler technology.  Vitalus […]

Read more

Live Better With: Too young for cancer? We get it!

/in

We are delighted to be partnering with Shine Cancer Support for their annual Shine Connect event – the UK’s only conference for young adults with cancer. Ceinwen Giles, Shine Cancer Support director, tells us what’s on the agenda: While cancer is usually thought of an “older person’s disease”, at Shine Cancer Support we know that there […]

Read more

Downing FOUR VCT invests £1.14 million in ADC Biotechnology Ltd

/in ,

Investment from Downing FOUR VCT (Healthcare and General share classes) advised by BioScience Managers Limited Funds used to progress development of Antibody Drug Conjugate (ADCs) technology Downing FOUR VCT is targeting dividends of at least 4% p.a. (of net assets) from the fourth year onwards * London, UK, 24 April 2018 – London-based investment management […]

Read more

RECELL Successful Pivotal Trial Data Presented at ABA Day 3

/in

Valencia, Calif., USA, and Melbourne, Australia, 13 April 2018 — AVITA Medical (ASX: AVH, OTCQX: AVMXY) today announced that its pivotal, controlled clinical trial in the treatment of deep full-thickness (third-degree) burns with the RECELL® Autologous Cell Harvesting Device achieved its co-primary endpoints, demonstrating a statistically significant reduction in donor skin requirements versus standard of […]

Read more